4//SEC Filing
Goldberg Itzhak 4
Accession 0001601485-21-000075
CIK 0001601485other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:02 PM ET
Size
8.2 KB
Accession
0001601485-21-000075
Insider Transaction Report
Form 4
Goldberg Itzhak
See Remarks
Transactions
- Tax Payment
Common Stock
2021-06-24$13.78/sh−47,410$653,310→ 2,020,068 total - Sale
Common Stock
2021-11-16$4.26/sh−38,495$163,808→ 1,870,068 total - Sale
Common Stock
2021-11-15$4.17/sh−111,505$465,243→ 1,908,563 total
Footnotes (4)
- [F1]The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").
- [F2]The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.48 inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.38 inclusive.
Documents
Issuer
Angion Biomedica Corp.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001607858
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 6:02 PM ET
- Size
- 8.2 KB